BIODESIX, INC. (BDSX) Debt Components
- 2026-06-30: Notes Payable to Bank, CurrentUSD $0.00; Notes Payable, CurrentUSD (m); Notes PayableUSD $46.82M; Long-term DebtUSD $50.00M.
- 2026-03-31: Notes Payable to Bank, CurrentUSD $2.00K; Notes Payable, CurrentUSD $2.00K; Notes PayableUSD $46.49M; Long-term DebtUSD $50.00M.
- 2025-12-31: Notes Payable to Bank, CurrentUSD $6.00K; Notes Payable, CurrentUSD $6.00K; Notes PayableUSD $47.45M; Long-term DebtUSD (m).
- 2025-12-31: Notes Payable to Bank, CurrentUSD (m); Notes Payable, CurrentUSD (m); Notes PayableUSD (m); Long-term DebtUSD $50.01M.
BIODESIX, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Notes Payable to Bank, Current USD | Notes Payable, Current USD | Notes Payable USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD | Convertible Notes Payable, Current USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Debt Instrument, Fee Amount USD | Debt Instrument, Annual Principal Payment USD | Debt Instrument, Unamortized Discount, Current USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | (m) | $46.82M | $50.00M | (m) | $50.00M | (m) | $3.18M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $2.00K | $2.00K | $46.49M | $50.00M | $0.00 | $50.00M | $2.00K | $3.51M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $6.00K | $6.00K | $47.45M | (m) | (m) | (m) | (m) | $2.56M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | (m) | (m) | $50.01M | $6.00K | $50.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $11.00K | $11.00K | $47.12M | $50.01M | $6.00K | (m) | $4.00K | $2.89M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $16.00K | $16.00K | $46.80M | $50.02M | $6.00K | (m) | $10.00K | $3.22M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $18.00K | $18.00K | $36.71M | $40.02M | $6.00K | (m) | $14.00K | $3.31M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $21.00K | $21.00K | $36.43M | (m) | (m) | (m) | (m) | $3.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | (m) | $40.03M | $21.00K | $5.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $29.00K | $29.00K | $36.14M | $40.04M | $21.00K | $6.00K | $13.00K | $3.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $37.00K | $37.00K | $35.84M | $40.05M | $21.00K | $7.00K | $25.00K | $4.21M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $45.00K | $45.00K | $35.56M | $40.06M | $21.00K | $6.00K | $38.00K | $4.51M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $51.00K | $51.00K | $35.28M | (m) | (m) | (m) | (m) | $4.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | $40.08M | $50.00K | $21.00K | (m) | (m) | (m) | $7.00K | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $50.00K | $50.00K | $25.00M | $30.09M | $50.00K | $21.00K | $13.00K | $5.09M | (m) | $6.00K | $30.00M | (m) | (m) | $30.00M | (m) |
| 2023-06-30 | $50.00K | $50.00K | $24.71M | $30.10M | $50.00K | $21.00K | $25.00K | $5.39M | (m) | $7.00K | $30.00M | (m) | (m) | (m) | (m) |
| 2023-03-31 | $50.00K | $50.00K | $25.13M | $30.11M | $50.00K | $21.00K | $37.00K | $4.98M | (m) | $7.00K | $30.00M | (m) | (m) | (m) | (m) |
| 2022-12-31 | $49.00K | $49.00K | $25.05M | (m) | (m) | (m) | (m) | $5.07M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | $30.13M | $49.00K | $50.00K | (m) | (m) | (m) | $21.00K | $7.00K | $30.00M | (m) | (m) | (m) |
| 2022-09-30 | $14.33M | $14.33M | $19.21M | $21.55M | $17.86M | $1.65M | $2.01M | $2.33M | (m) | $25.00K | $6.00K | (m) | (m) | (m) | (m) |
| 2022-06-30 | $11.77M | $11.77M | $20.37M | $23.32M | $14.62M | $1.65M | $7.02M | $2.95M | (m) | $25.00K | $6.00K | (m) | (m) | (m) | (m) |
| 2022-03-31 | $51.00K | $51.00K | $10.11M | $10.16M | $49.00K | $4.05M | $36.00K | $59.00K | (m) | $4.82M | $1.21M | (m) | (m) | (m) | (m) |
| 2021-12-31 | $19.00K | $19.00K | $10.01M | (m) | (m) | (m) | (m) | $63.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | $10.07M | $19.00K | $15.00K | (m) | (m) | (m) | $4.02M | $4.82M | $1.21M | (m) | (m) | (m) |
| 2021-09-30 | $20.00K | $20.00K | $30.00M | $30.08M | $19.00K | $15.00K | $5.00K | $85.00K | (m) | $13.22M | $14.42M | (m) | (m) | (m) | (m) |
| 2021-06-30 | $3.11M | $3.11M | $33.06M | $33.17M | $2.42M | $15.00K | $691.00K | $109.00K | (m) | $13.22M | $14.42M | (m) | (m) | (m) | (m) |
| 2021-03-31 | $2.71M | $2.71M | $33.03M | $33.12M | $416.00K | $8.33M | $2.71M | $90.00K | (m) | $10.00M | $10.00M | (m) | (m) | (m) | (m) |
| 2020-12-31 | $11.84M | $11.84M | $27.77M | (m) | (m) | (m) | (m) | $313.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | $28.08M | $11.84M | $13.92M | (m) | (m) | (m) | $2.32M | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $7.20M | $7.20M | $24.44M | $24.79M | $10.32M | $12.20M | (m) | $349.00K | $26.60M | $2.27M | (m) | (m) | $238.00K | (m) | (m) |
| 2019-12-31 | $12.16M | $12.16M | $35.97M | (m) | (m) | (m) | (m) | $1.46M | $13.16M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $170.00K | (m) | $1.00M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |